Keros Therapeutics Inc
NASDAQ:KROS
Keros Therapeutics Inc
NASDAQ:KROS
Price:
10.61
USD
-4.24%
Market Closed
Market Cap:
$209.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Keros Therapeutics Inc
NASDAQ:KROS
|
US |
|
N
|
note Inc
TSE:5243
|
JP |
|
Mayur Resources Ltd
ASX:MRL
|
AU |
|
G
|
Grainger PLC
OTC:GRGTF
|
UK |
|
Shaanxi Coal Industry Co Ltd
SSE:601225
|
CN |
|
S
|
StandardAero, Inc.
NYSE:SARO
|
US |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
CN |
|
W
|
WEG SA
OTC:WEGZY
|
BR |
|
Abdullah Al Othaim Markets CompanySJSC
SAU:4001
|
SA |
|
S
|
Suzhou Delphi Laser Co Ltd
SSE:688170
|
CN |
|
First Niles Financial Inc
OTC:FNFI
|
US |
|
Top Shelf International Holdings Ltd
ASX:TSI
|
AU |
|
D
|
Datalogic SpA
MIL:DAL
|
IT |
|
S
|
Sekisui Jushi Corp
TSE:4212
|
JP |
|
Z
|
Zhejiang Yasha Decoration Co Ltd
SZSE:002375
|
CN |
|
Shenzhen YHLO Biotech Co Ltd
SSE:688575
|
CN |
|
Hari Govind International Ltd
BSE:531971
|
IN |
|
Chant Sincere Co Ltd
TWSE:6205
|
TW |
|
Lazard Ltd
NYSE:LAZ
|
BM |
|
N
|
Ningxia Zhongke Biotechnology Co Ltd
SSE:600165
|
CN |
|
L
|
Larq SA
WSE:LRQ
|
PL |
|
Salon Media Group Inc
OTC:SLNM
|
US |
|
MGIC Investment Corp
NYSE:MTG
|
US |
|
M
|
Maven Wireless Sweden AB
STO:MAVEN
|
SE |
Multiples-Based Value
The Multiples-Based Value of one
KROS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 10.61 USD,
Keros Therapeutics Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KROS Multiples-Based Value
LOCKED
Multiples Across Competitors
KROS Competitors Multiples
Keros Therapeutics Inc Competitors
Keros Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Keros Therapeutics Inc
NASDAQ:KROS
|
207.4m USD | 1.3 | 3.7 | -1.1 | -1.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.6 | 12.3 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.2 | 27.8 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.2 | 35.1 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
